S&T Bank’s iShares Biotechnology ETF IBB Stock Holding History

S&T Bank’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-240	Closed	-$31.7K	–	398
2024 Q4	$31.7K	Buy	+240	New	+$33.7K	0.01%	167

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

S&T Bank's IBB Position: Q1 2025 in Review

S&T Bank sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 240 shares — an estimated $31.7K sold.

S&T Bank first reported a position in IBB in Q4 2024 and held it in 1 quarter. The position peaked at $31.7K in Q4 2024. 831 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

S&T Bank reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
S&T Bank sold 240 iShares Biotechnology ETF shares in Q1 2025, an estimated $31.7K.
S&T Bank first reported a position in iShares Biotechnology ETF in Q4 2024 and held it in 1 quarter.
S&T Bank's iShares Biotechnology ETF position peaked at $31.7K in Q4 2024.
831 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on S&T Bank's 13F filing for Q1 2025, filed 15 May 2025.